Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 530 participants.
Also called NCT04298723
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 530 participants
- Sponsor
- Registry
-
NCT04298723
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany, Poland
- Registry status
- Recruiting
Technical summary
Registry record NCT04298723. Randomized; single masking; primary purpose prevention. Start 2020-06-16 (actual); primary completion 2029-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
- Acronym
- CLEARANCE
- Condition
- Intracranial Hemorrhages
- Condition
- Atrial Fibrillation (AF)
- Condition
- Atrial Flutter
- Intervention (Device)
- Percutaneous closure of the LAA (Watchman / Watchman FLX)
- Lead sponsor
- Jena University Hospital
- Collaborator
- KCRI
Record details
- Record id
cardio:ct-nct04298723- Content hash
20b366bf77b655e1fa230b1e1a7785291336efbbba6c230a38ba8facbc1cf0eb